{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T19:56:11Z","timestamp":1792439771646,"version":"4.5.0"},"reference-count":63,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>This review aims to compare the efficacies of fluorescence cystoscopy, narrow-band imaging (NBI), and white light cystoscopy in the treatment and diagnosis of bladder cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The authors searched PubMed, EMbase, Web of Science, and the Cochrane Library from January 1990 to April 2022. A total of 26 randomized controlled studies and 22 prospective single-arm studies were selected. Most patients had nonmuscle-invasive bladder cancer. The study protocol has been registered at PROSPERO.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In the pairwise meta-analysis, 5-aminolevulinic acid (5-ALA) reduced the short-term and long-term recurrence rates of bladder cancer compared with white light cystoscopy (WLC); however, no statistical difference was observed in intermediate-term recurrence rates (RR=0.79, 95% CI: 0.57\u20131.09). Hexaminolevulinic acid and NBI reduced short-term, intermediate-term, and long-term recurrence rates. The sensitivity of 5-ALA, hexaminolevulinic acid, NBI, and WLC for bladder cancer were 0.89 (95% CI: 0.81\u20130.94), 0.96 (95% CI: 0.92\u20130.98), 0.96 (95% CI: 0.92\u20130.98), and 0.75 (95% CI: 0.70\u20130.79), respectively; however, only NBI had the same specificity as WLC (0.74 vs. 0.74). Compared with WLC, 5-ALA improved the detection rate of carcinoma in situ and Ta stage bladder cancer but had no advantage in T1 stage tumors (OR=2.39, 95% CI:0.79\u20137.19). Hexaminolevulinic acid and NBI improved the detection rates of all nonmuscular-invasive bladder cancers. In the network meta-analysis, there was no significant difference in either recurrence or detection rates between 5-ALA, hexaminolevulinic acid, and NBI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Fluorescence cystoscopy and NBI are advantageous for treating and diagnosing patients with nonmuscle-invasive bladder cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000000592","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T06:00:38Z","timestamp":1690869638000},"page":"3169-3177","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":23,"title":["Diagnostic and therapeutic effects of fluorescence cystoscopy and narrow-band imaging in bladder cancer: a systematic review and network meta-analysis"],"prefix":"10.1097","volume":"109","author":[{"given":"Zhinan","family":"Fan","sequence":"first","affiliation":[{"name":"Department of Urology , Meishan People\u2019s Hospital, Meishan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjin","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Urology , Meishan People\u2019s Hospital, Meishan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinquan","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Urology , Meishan People\u2019s Hospital, Meishan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology , Meishan People\u2019s Hospital, Meishan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Urology , Meishan People\u2019s Hospital, Meishan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Urology , Meishan People\u2019s Hospital, Meishan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,10]]},"reference":[{"key":"R1-20250824","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3390\/medicina57080749","article-title":"Bladder cancer: current challenges and future directions","volume":"57","author":"Dobruch","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"R2-20250824","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"R3-20250824","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/cas.15193","article-title":"Current status of photodynamic technology for urothelial cancer","volume":"113","author":"Inoue","year":"2022","journal-title":"Cancer Sci"},{"key":"R4-20250824","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.juro.2012.03.127","article-title":"New optical imaging technologies for bladder cancer: considerations and perspectives","volume":"188","author":"Liu","year":"2012","journal-title":"J Urol"},{"key":"R5-20250824","doi-asserted-by":"crossref","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"key":"R6-20250824","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"R7-20250824","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0022-5347(05)66442-7","article-title":"Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer","volume":"165","author":"Riedl","year":"2001","journal-title":"J Urol"},{"key":"R8-20250824","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1464-410X.2004.05715.x","article-title":"5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta\/T1 bladder cancer","volume":"96","author":"Babjuk","year":"2005","journal-title":"BJU Int"},{"key":"R9-20250824","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0022-5347(05)64661-7","article-title":"Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy","volume":"168","author":"Kriegmair","year":"2002","journal-title":"J Urol"},{"key":"R10-20250824","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0090-4295(02)01961-1","article-title":"Do patients profit from 5-aminolevulinic acid-induced fluorescence diagnosis in transurethral resection of bladder carcinoma","volume":"60","author":"Filbeck","year":"2002","journal-title":"Urology"},{"key":"R11-20250824","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/cncr.25523","article-title":"Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy: a multicenter randomized, double-blind, placebo-controlled trial","volume":"117","author":"Stenzl","year":"2011","journal-title":"Cancer"},{"key":"R12-20250824","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.eururo.2009.10.030","article-title":"Transurethral resection of non-muscle-invasive bladder transitional cell cancers with or without 5-aminolevulinic Acid under visible and fluorescent light: results of a prospective, randomised, multicentre study","volume":"57","author":"Schumacher","year":"2010","journal-title":"Eur Urol"},{"key":"R13-20250824","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00345-016-1927-y","article-title":"Results of a prospective randomized study assessing the efficacy of fluorescent cystoscopy-assisted transurethral resection and single instillation of doxorubicin in patients with non-muscle-invasive bladder cancer","volume":"35","author":"Rolevich","year":"2017","journal-title":"World J Urol"},{"key":"R14-20250824","first-page":"123","article-title":"Photodynamic diagnosis of non-muscle invasive bladder cancer using hexaminolevulinic acid","volume":"52","author":"Dr\u0103goescu","year":"2011","journal-title":"Rom J Morphol Embryol"},{"key":"R15-20250824","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.juro.2010.06.148","article-title":"Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer","volume":"184","author":"Stenzl","year":"2010","journal-title":"J Urol"},{"key":"R16-20250824","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.urology.2010.02.067","article-title":"HAL blue-light cystoscopy in high-risk nonmuscle-invasive bladder cancer-re-TURBT recurrence rates in a prospective, randomized study","volume":"76","author":"Geavlete","year":"2010","journal-title":"Urology"},{"key":"R17-20250824","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.urology.2012.03.067","article-title":"Hexaminolevulinate-induced fluorescence versus white light during transurethral resection of noninvasive bladder tumor: does it reduce recurrences","volume":"80","author":"Karaolides","year":"2012","journal-title":"Urology"},{"key":"R18-20250824","first-page":"1279","article-title":"Improved diagnosis and long-term recurrence rate reduction for non-muscle-invasive bladder cancer patients undergoing fluorescent hexylaminolevulinate photodynamic diagnosis","volume":"58","author":"Dr\u0103goescu","year":"2017","journal-title":"Rom J Morphol Embryol"},{"key":"R19-20250824","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/bju.12355","article-title":"Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C versus conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasive bladder cancer","volume":"112","author":"O\u2019Brien","year":"2013","journal-title":"BJU Int"},{"key":"R20-20250824","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.urolonc.2014.04.005","article-title":"Assessment of diagnostic gain with hexaminolevulinate (HAL) in the setting of newly diagnosed non-muscle-invasive bladder cancer with positive results on urine cytology","volume":"32","author":"Neuzillet","year":"2014","journal-title":"Urol Oncol"},{"issue":"8 Pt 2","key":"R21-20250824","doi-asserted-by":"crossref","first-page":"E297","DOI":"10.1111\/j.1464-410X.2011.10090.x","article-title":"Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta\/T1 patients: a randomized two-centre study","volume":"108","author":"Hermann","year":"2011","journal-title":"BJU International"},{"key":"R22-20250824","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s11255-013-0603-z","article-title":"Hexaminolevulinate-guided transurethral resection of non-muscle-invasive bladder cancer does not reduce the recurrence rates after a 2-year follow-up: a prospective randomized trial","volume":"46","author":"Gkritsios","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"R23-20250824","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.urology.2019.12.002","article-title":"DaBlaCa-11: photodynamic diagnosis in flexible cystoscopy-a randomized study with focus on recurrence","volume":"137","author":"Drejer","year":"2020","journal-title":"Urology"},{"key":"R24-20250824","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.urology.2011.08.081","article-title":"Narrow band imaging cystoscopy and bipolar plasma vaporization for large nonmuscle-invasive bladder tumors--results of a prospective, randomized comparison to the standard approach","volume":"79","author":"Geavlete","year":"2012","journal-title":"Urology"},{"key":"R25-20250824","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.eururo.2012.01.018","article-title":"A randomized prospective trial to assess the impact of transurethral resection in narrow band imaging modality on non-muscle-invasive bladder cancer recurrence","volume":"61","author":"Naselli","year":"2012","journal-title":"Eur Urol"},{"key":"R26-20250824","first-page":"3032","article-title":"Narrow band imaging-assisted holmium laser resection reduced the recurrence rate of non-muscle invasive bladder cancer: a prospective, randomized controlled study","volume":"95","author":"Ma","year":"2015","journal-title":"Zhonghua yi xue za zhi"},{"key":"R27-20250824","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.eururo.2016.03.053","article-title":"The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) versus conventional white light imaging-assisted TURBT in primary non-muscle-invasive bladder cancer patients: trial protocol and 1-year results","volume":"70","author":"Naito","year":"2016","journal-title":"Eur Urol"},{"key":"R28-20250824","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.eururo.2014.06.049","article-title":"Randomized trial of narrow-band versus white-light cystoscopy for restaging (second-look) transurethral resection of bladder tumors","volume":"67","author":"Herr","year":"2015","journal-title":"Eur Urol"},{"key":"R29-20250824","first-page":"463","article-title":"Comparison of 3-month recurrence rates after white-light versus narrow-band imaging transurethral resection for non-muscle invasive bladder cancer: a prospective, randomized control trial","volume":"101","author":"Buaban","year":"2018","journal-title":"J Med Assoc Thai"},{"key":"R30-20250824","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4111\/icu.2018.59.2.98","article-title":"Detection and recurrence rate of transurethral resection of bladder tumors by narrow-band imaging: Prospective, randomized comparison with white light cystoscopy","volume":"59","author":"Kim","year":"2018","journal-title":"Investig Clin Urol"},{"key":"R31-20250824","first-page":"e240","article-title":"Mp22-16 recurrence rate of transurethral resection of bladder tumor using narrow band imaging: a randomized control trial, pilot study","volume":"191","author":"Lee","year":"2014","journal-title":"J Urol"},{"key":"R32-20250824","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s00345-019-02926-0","article-title":"Narrow-band imaging assisted cystoscopy in the follow-up of patients with transitional cell carcinoma of the bladder: a randomized study in comparison with white light cystoscopy","volume":"38","author":"Tschirdewahn","year":"2020","journal-title":"World J Urol"},{"key":"R33-20250824","doi-asserted-by":"crossref","first-page":"10905","DOI":"10.1038\/srep10905","article-title":"A comparison of NBI and WLI cystoscopy in detecting non-muscle-invasive bladder cancer: a prospective, randomized and multi-center study","volume":"5","author":"Ye","year":"2015","journal-title":"Sci Rep"},{"key":"R34-20250824","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11255-011-0036-5","article-title":"Narrow-band imaging flexible cystoscopy in the detection of primary non-muscle invasive bladder cancer: a \u201csecond look\u201d matters?","volume":"44","author":"Shen","year":"2012","journal-title":"Int Urol Nephrol"},{"key":"R35-20250824","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1097\/01.ju.0000181814.73466.14","article-title":"Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study","volume":"174","author":"Daniltchenko","year":"2005","journal-title":"J Urol"},{"key":"R36-20250824","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.urology.2006.12.023","article-title":"Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study","volume":"69","author":"Denzinger","year":"2007","journal-title":"Urology"},{"key":"R37-20250824","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.juro.2012.03.007","article-title":"Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy","volume":"188","author":"Grossman","year":"2012","journal-title":"J Urol"},{"key":"R38-20250824","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/end.1999.13.117","article-title":"Clinical results of the transurethreal resection and evaluation of superficial bladder carcinomas by means of fluorescence diagnosis after intravesical instillation of 5-aminolevulinic acid","volume":"13","author":"Filbeck","year":"1999","journal-title":"J Endourol"},{"key":"R39-20250824","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1464-410x.1999.00917.x","article-title":"Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5-aminolaevulinic acid","volume":"83","author":"Koenig","year":"1999","journal-title":"BJU Int"},{"key":"R40-20250824","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/iju.13718","article-title":"Oral 5-aminolevulinic acid-mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: a multicenter phase III study","volume":"25","author":"Nakai","year":"2018","journal-title":"Int J Urol"},{"key":"R41-20250824","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pdpdt.2015.12.011","article-title":"The clinical trial on the safety and effectiveness of the photodynamic diagnosis of non-muscle-invasive bladder cancer using fluorescent light-guided cystoscopy after oral administration of 5-aminolevulinic acid (5-ALA)","volume":"13","author":"Inoue","year":"2016","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"R42-20250824","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0022-5347(01)61605-7","article-title":"Is everything all right if nothing seems wrong? A simple method of assessing the diagnostic value of endoscopic procedures when a gold standard is absent","volume":"161","author":"Schneeweiss","year":"1999","journal-title":"J Urol"},{"key":"R43-20250824","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/01.ju.0000060782.52358.04","article-title":"Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer \u2013 a multicenter study","volume":"170","author":"Jichlinski","year":"2003","journal-title":"J Urol"},{"key":"R44-20250824","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.juro.2007.03.028","article-title":"A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study","volume":"178","author":"Fradet","year":"2007","journal-title":"J Urol"},{"key":"R45-20250824","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/bju.13020","article-title":"Effectiveness of hexaminolevulinate fluorescence cystoscopy for the diagnosis of non-muscle-invasive bladder cancer in daily clinical practice: a Spanish multicentre observational study","volume":"116","author":"Palou","year":"2015","journal-title":"BJU Int"},{"key":"R46-20250824","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1007\/s00464-012-2387-0","article-title":"A comparison of hexaminolevulinate (Hexvix(R)) fluorescence cystoscopy and white-light cystoscopy for detection of bladder cancer: results of the HeRo observational study","volume":"26","author":"Lapini","year":"2012","journal-title":"Surg Endosc"},{"key":"R47-20250824","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.acuro.2011.03.003","article-title":"Hexaminolevulinate photodynamic diagnosis in non-muscle invasive bladder cancer: experience of the BLUE group","volume":"35","author":"Burgues","year":"2011","journal-title":"Actas Urol Esp"},{"key":"R48-20250824","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/01.ju.0000169257.19841.2a","article-title":"Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study","volume":"174","author":"Jocham","year":"2005","journal-title":"J Urol"},{"key":"R49-20250824","doi-asserted-by":"crossref","first-page":"821","DOI":"10.4111\/kju.2012.53.12.821","article-title":"Efficacy and safety of hexaminolevulinate fluorescence cystoscopy in the diagnosis of bladder cancer","volume":"53","author":"Lee","year":"2012","journal-title":"Korean J Urol"},{"key":"R50-20250824","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.eururo.2009.07.042","article-title":"Fluorescence cystoscopy with high-resolution optical coherence tomography imaging as an adjunct reduces false-positive findings in the diagnosis of urothelial carcinoma of the bladder","volume":"56","author":"Schmidbauer","year":"2009","journal-title":"Eur Urol"},{"key":"R51-20250824","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.purol.2012.12.002","article-title":"Ciblage diagnostique par Hexvix\u00ae des tumeurs uroth\u00e9liales de vessie: r\u00e9sultats apr\u00e8s quatre ans d\u2019\u00e9valuation prospective monocentrique","volume":"23","author":"Ferr\u00e9","year":"2013","journal-title":"Progr\u00e8s en Urologie"},{"key":"R52-20250824","doi-asserted-by":"crossref","first-page":"361.e1","DOI":"10.1016\/j.urolonc.2018.04.013","article-title":"Blue light cystoscopy for the diagnosis of bladder cancer: results from the US prospective multicenter registry","volume":"36","author":"Daneshmand","year":"2018","journal-title":"Urol Oncol"},{"key":"R53-20250824","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1464-410X.2009.08839.x","article-title":"Hexylaminolaevulinate fluorescence cystoscopy in patients previously treated with intravesical bacille Calmette-Guerin","volume":"105","author":"Ray","year":"2010","journal-title":"BJU Int"},{"key":"R54-20250824","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.purol.2010.04.007","article-title":"Prospective monocentric evaluation of bladder tumor targeting by Hexvix (R) fluorescence: preliminary results","volume":"20","author":"Saint","year":"2010","journal-title":"Prog Urol"},{"key":"R55-20250824","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1089\/end.2010.0055","article-title":"Evaluation of narrow-band imaging as a complementary method for the detection of bladder cancer","volume":"24","author":"Tatsugami","year":"2010","journal-title":"J Endourol"},{"key":"R56-20250824","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.urology.2009.11.075","article-title":"Narrow band imaging cystoscopy improves the detection of non-muscle-invasive bladder cancer","volume":"76","author":"Cauberg","year":"2010","journal-title":"Urology"},{"key":"R57-20250824","doi-asserted-by":"crossref","first-page":"e33240","DOI":"10.5812\/numonthly.33240","article-title":"A comparison of the progression and recurrence risk index in non-muscle-invasive bladder tumors detected by narrow-band imaging versus white light cystoscopy, based on the EORTC scoring system","volume":"8","author":"Shadpour","year":"2016","journal-title":"Nephrourol Mon"},{"key":"R58-20250824","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.pdpdt.2011.12.004","article-title":"Pivotal roles of peptide transporter PEPT1 and ATP-binding cassette (ABC) transporter ABCG2 in 5-aminolevulinic acid (ALA)-based photocytotoxicity of gastric cancer cells in vitro","volume":"9","author":"Hagiya","year":"2012","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"R59-20250824","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000245896","article-title":"Regulation of 5-aminolevulinic acid-mediated protoporphyrin IX accumulation in human urothelial carcinomas","volume":"76","author":"Inoue","year":"2009","journal-title":"Pathobiology"},{"key":"R60-20250824","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0090-4295(94)80203-3","article-title":"Intravesical instillation of 5-aminolevulinic acid: the fluorescent metabolite is limited to urothelial cells","volume":"44","author":"Steinbach","year":"1994","journal-title":"Urology"},{"key":"R61-20250824","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1089\/pho.2016.4217","article-title":"Photodynamic diagnosis and narrow-band imaging in the management of bladder cancer: a review","volume":"35","author":"Kutwin","year":"2017","journal-title":"Photomed Laser Surg"},{"key":"R62-20250824","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.urology.2009.04.095","article-title":"Predictors of false positives in 5-aminolevulinic acid-induced photodynamic diagnosis of bladder carcinoma: identification of patient groups that may benefit most from highly specific optical diagnostics","volume":"74","author":"Draga","year":"2009","journal-title":"Urology"},{"key":"R63-20250824","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1089\/end.2008.0574","article-title":"Hexaminolevulinate fluorescence cystoscopy and transurethral resection of the bladder in noninvasive bladder tumors","volume":"23","author":"Geavlete","year":"2009","journal-title":"J Endourol"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000000592","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T19:04:50Z","timestamp":1756062290000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000000592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":63,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000000592","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,1]]},"assertion":[{"value":"2023-03-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}